PE20070107A1 - Sulfonamidas como potenciadores del receptor de glutamato - Google Patents
Sulfonamidas como potenciadores del receptor de glutamatoInfo
- Publication number
- PE20070107A1 PE20070107A1 PE2006000603A PE2006000603A PE20070107A1 PE 20070107 A1 PE20070107 A1 PE 20070107A1 PE 2006000603 A PE2006000603 A PE 2006000603A PE 2006000603 A PE2006000603 A PE 2006000603A PE 20070107 A1 PE20070107 A1 PE 20070107A1
- Authority
- PE
- Peru
- Prior art keywords
- cyane
- halo
- sulfonamides
- sulfonylamino
- thiophen
- Prior art date
Links
- 102000018899 Glutamate Receptors Human genes 0.000 title 1
- 108010027915 Glutamate Receptors Proteins 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- -1 CYANE Chemical class 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 102000003678 AMPA Receptors Human genes 0.000 abstract 1
- 108090000078 AMPA Receptors Proteins 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 231100000876 cognitive deterioration Toxicity 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A ES 1, 2, ENTRE OTROS; R ES H, HALO, -COOH, CH2COOH; R1 ES FENILO OPCIONALMENTE SUSTITUIDO CON UN PRIMER SUSTITUYENTE SELECCIONADO ENTRE HALO, CIANO, -COOH, ENTRE OTROS Y UN SEGUNDO SUSTITUYENTE SELECCIONADO DE HALO, TRIFLUOROMETILO, CIANO, NITRO, HIDROXI, ENTRE OTROS; R2 ES ALQUILO C1-C4, DIMETILAMINO. SON COMPUESTOS PREFERIDOS: ACIDO 2-CIANO-4'-[3-(PROPAN-2-SULFONILAMINO)-TIOFEN-2-IL]-BIFENIL-4-CARBOXILICO; 2-ETOXI-4'-[3-(PROPAN-2-SULFONILAMINO)-TIOFEN-2-IL]-BIFENIL-4-CARBOXILICO; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON POTENCIADORES DEL RECEPTOR AMPA (ACIDO PROPIONICO DE ALFA-AMINO-3-HIDROXI-5-METIL-4-ISOXAZOL), UTILES EN EL TRATAMIENTO DE PARKINSON, ALZHEIMER, DETERIORO COGNITIVO, ENTRE OTROS
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05380117 | 2005-06-06 | ||
| EP05380187 | 2005-08-18 | ||
| US72420605P | 2005-10-06 | 2005-10-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070107A1 true PE20070107A1 (es) | 2007-02-09 |
Family
ID=37227734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000603A PE20070107A1 (es) | 2005-06-06 | 2006-06-02 | Sulfonamidas como potenciadores del receptor de glutamato |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7393868B2 (es) |
| AR (1) | AR057347A1 (es) |
| CR (1) | CR9574A (es) |
| CY (1) | CY1108718T1 (es) |
| DE (1) | DE602006003661D1 (es) |
| DO (1) | DOP2006000124A (es) |
| EC (1) | ECSP077979A (es) |
| HK (1) | HK1116182A1 (es) |
| IL (1) | IL187157A0 (es) |
| JO (1) | JO2539B1 (es) |
| MA (1) | MA29910B1 (es) |
| MY (1) | MY140858A (es) |
| NO (1) | NO20080079L (es) |
| PE (1) | PE20070107A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006003661D1 (de) * | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| CN101600436A (zh) * | 2006-08-31 | 2009-12-09 | 艾伯塔大学校董 | 使用正变构ampa受体调节剂抑制呼吸抑制的方法 |
| CA2729767A1 (en) * | 2008-07-07 | 2010-01-14 | Fasgen, Inc. | Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| US9527807B2 (en) | 2011-04-05 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| JP2016521755A (ja) | 2013-06-13 | 2016-07-25 | ヴェロサイエンス，リミテッド・ライアビリティー・カンパニー | 代謝障害を治療するための組成物および方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| AU5235699A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Sulfonamide derivatives |
| ATE402140T1 (de) | 1999-12-08 | 2008-08-15 | Lilly Co Eli | Cyclopentyl sulfonamid derivaten |
| AU2002212959A1 (en) | 2000-10-13 | 2002-04-29 | Eli Lilly And Company | Cycloalkylfluorosulfonamide derivatives |
| US20040087604A1 (en) * | 2001-01-22 | 2004-05-06 | Tatsuo Tsuri | Hetero-tricyclic compounds having substituted amino groups |
| CA2447746A1 (en) | 2001-05-30 | 2002-12-12 | Eli Lilly And Company | Cycloalkenylsulfonamide derivatives |
| US6881741B2 (en) | 2001-06-11 | 2005-04-19 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| ES2383115T3 (es) | 2004-01-09 | 2012-06-18 | Eli Lilly And Company | Compuestos de tiofeno y furano |
| EP1786769A1 (en) | 2004-08-09 | 2007-05-23 | Glaxo Group Limited | Compounds which potentiate glutamate receptor and uses thereof in medicine |
| DE602006003661D1 (de) * | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
-
2006
- 2006-05-25 DE DE602006003661T patent/DE602006003661D1/de active Active
- 2006-06-01 DO DO2006000124A patent/DOP2006000124A/es unknown
- 2006-06-02 AR ARP060102320A patent/AR057347A1/es not_active Application Discontinuation
- 2006-06-02 PE PE2006000603A patent/PE20070107A1/es not_active Application Discontinuation
- 2006-06-05 MY MYPI20062598A patent/MY140858A/en unknown
- 2006-06-05 US US11/446,840 patent/US7393868B2/en not_active Expired - Fee Related
- 2006-06-06 JO JO2006164A patent/JO2539B1/en active
- 2006-06-06 US US11/422,473 patent/US7652064B2/en not_active Expired - Fee Related
-
2007
- 2007-11-05 IL IL187157A patent/IL187157A0/en unknown
- 2007-12-03 EC EC2007007979A patent/ECSP077979A/es unknown
- 2007-12-06 CR CR9574A patent/CR9574A/es unknown
-
2008
- 2008-01-04 MA MA30543A patent/MA29910B1/fr unknown
- 2008-01-04 NO NO20080079A patent/NO20080079L/no not_active Application Discontinuation
- 2008-06-12 HK HK08106513.7A patent/HK1116182A1/xx not_active IP Right Cessation
-
2009
- 2009-01-21 CY CY20091100077T patent/CY1108718T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1116182A1 (en) | 2008-12-19 |
| US20060276532A1 (en) | 2006-12-07 |
| IL187157A0 (en) | 2008-02-09 |
| DE602006003661D1 (de) | 2008-12-24 |
| MA29910B1 (fr) | 2008-11-03 |
| CY1108718T1 (el) | 2014-04-09 |
| JO2539B1 (en) | 2010-09-05 |
| DOP2006000124A (es) | 2007-02-15 |
| AR057347A1 (es) | 2007-11-28 |
| ECSP077979A (es) | 2008-01-23 |
| US20070142441A1 (en) | 2007-06-21 |
| NO20080079L (no) | 2008-01-04 |
| US7393868B2 (en) | 2008-07-01 |
| CR9574A (es) | 2008-05-30 |
| MY140858A (en) | 2010-01-29 |
| US7652064B2 (en) | 2010-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20110150A1 (es) | Amidofenoxiindazoles como inhibidores de c-met | |
| PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
| PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
| PE20091444A1 (es) | Derivados de isoxazolo-pirazina | |
| PE20141700A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido) pirimidina | |
| PE20211700A1 (es) | Compuesto heterociclico y su uso | |
| PE20071322A1 (es) | Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa | |
| PE20070107A1 (es) | Sulfonamidas como potenciadores del receptor de glutamato | |
| PE20070519A1 (es) | Derivados de fenilmorfolina y feniltiomorfolina como agonistas de adrenoreceptores alfa 2c | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| PE20121182A1 (es) | Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina | |
| PE20070136A1 (es) | COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1 | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| PE20121440A1 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos | |
| PE20150041A1 (es) | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco | |
| PE20091816A1 (es) | Inhibidores de bace | |
| PE20060623A1 (es) | Compuestos de sulfonamida como potenciadores del receptor de glutamato | |
| PE20061084A1 (es) | Compuestos derivados de 2-ciano-3-(halo)alcoxi-bencenosulfonamida | |
| PE20081545A1 (es) | Derivados de sulfonamida como inhibidores de acido graso sintasas | |
| PE20130647A1 (es) | Indoles | |
| PE20071031A1 (es) | Derivados de tiadiazolidinona como inhibidores de ptpasas | |
| PE20110672A1 (es) | 4-fenil-1-h-pirazoles insecticidas | |
| PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
| PE20051054A1 (es) | Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento | |
| PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |